Drug Trial Radar · NCT03860935
Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy
Last checked: Nov 19, 2026Latest source record: Jun 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
632
Actual
Start
Mar 19, 2019
Primary completion
May 11, 2023
Study completion May 11, 2023
Sponsor
- Lead sponsor
- Eidos Therapeutics, a BridgeBio companyIndustry
- Sponsor type
- Industry
- First posted
- Mar 4, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase 3 efficacy and safety study to evaluate acoramidis (AG10) HCl 800 mg administered orally twice a day compared to placebo in subjects with symptomatic Transthyretin Amyloid Cardiomyopathy (ATTR-CM).
Conditions
- Amyloidosis
- Amyloid Cardiomyopathy
- Transthyretin Amyloidosis
- Cardiomyopathies
- Heart Diseases
Interventions
acoramidisDrug
TTR stabilizer administered orally twice daily (BID)
Placebo Oral TabletDrug
Non-active control administered orally twice daily (BID)
Primary outcomes
What the sponsor says the trial is designed to measure.
- A Hierarchical Combination of All-Cause Mortality, Cumulative Frequency of CV-related Hospitalization, Change From Baseline in NT-proBNP and Change From Baseline in 6MWT at the Last Available Visit Where Both Subjects Had Non-missing Assessments.Time frame: Baseline up to Month 30
Locations
104 sites in 18 countries. Site status is shown where the registry gives one.
Cedars-Sinai Medical Center
Los Angeles, California
Pacific Heart Institute
Santa Monica, California
University of Colorado Hospital - Anschutz Medical Campus
Aurora, Colorado
Yale School of Medicine
New Haven, Connecticut
MedStar Washington Hospital Center
Washington D.C., District of Columbia
University of Miami - Sylvester Comprehensive Cancer Center
Miami, Florida
Piedmont Heart Institute Athens
Athens, Georgia
Emory Heart and Vascular Center
Atlanta, Georgia
Northwestern University
Chicago, Illinois
The University of Chicago Medical Center
Chicago, Illinois
NorthShore University Health System
Evanston, Illinois
Indiana University
Indianapolis, Indiana
MedStar Medical Group Cardiology at Franklin Square Medical Center
Baltimore, Maryland
Boston University School of Medicine
Boston, Massachusetts
Saint Elizabeth's Medical Center
Boston, Massachusetts
Mayo Clinic
Rochester, Minnesota
Saint Luke's Hospital - Kansas City
Kansas City, Missouri
Washington University School of Medicine
St Louis, Missouri
Newark Beth Israel Medical Center
Newark, New Jersey
North Shore University Hospital
Manhasset, New York
New York University Langone Health
New York, New York
Mount Sinai Hospital
New York, New York
Columbia University Medical Center
New York, New York
Laurelton Heart Specialist
Rosedale, New York
Montefiore Medical Center
The Bronx, New York
University of North Carolina - Chapel Hill
Chapel Hill, North Carolina
Duke University Health System
Durham, North Carolina
Cleveland Clinic
Cleveland, Ohio
Oregon Health and Science University
Portland, Oregon
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
Allegheny General Hospital
Pittsburgh, Pennsylvania
University of Pittsburgh
Pittsburgh, Pennsylvania
The Medical University of South Carolina
Charleston, South Carolina
Prisma Health - Greenville Memorial Hospital
Greenville, South Carolina
University of Texas Southwestern Medical Center
Dallas, Texas
University of Utah
Salt Lake City, Utah
Virginia Commonwealth University Medical Center
Richmond, Virginia
Carilion Clinic Roanoke Heart Institute
Roanoke, Virginia
University of Washington School of Medicine
Seattle, Washington
Providence Sacred Heart Medical Center
Spokane, Washington
Showing 40 of 104 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.